Mc-Lys (PEG12) -Cap-Ala-Ala-PABC-exatecan
Mc-Lys (PEG12) -Cap-Ala-Ala-PABC-exatecan (compound 12) is a Drug-Linker Conjugate for ADC. Mc-Lys (PEG12) -Cap-Ala-Ala-PABC-exatecan contains the ADC linker (Mc-Lys (PEG12) -Cap-Ala-Ala-PABC) (HY-178146) and a DNA topoisomerase I inhibitor Exatecan (HY-13631) . Mc-Lys (PEG12) -Cap-Ala-Ala-PABC-exatecan can be used for the development of ADC targeting HER2-positive breast cancer[1].
Product Specifications
CAS Number
[3067680-81-0]
UNSPSC
12352005
Target
Drug-Linker Conjugates for ADC; Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
Molecular Formula
C86H123FN10O26
Molecular Weight
1731.95
References & Citations
[1]Auvert E, et al. Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items